Popular Articles
Natural Remedies

Physicians Frequently Fail To Inform Patients About Abnormal Test Results
New research shows that physicians failed to report clinically significant abnormal test results to patients -- or to document that they had informed them -- in one out of every 14 cases of abnormal results. In some medical groups, the failure rate is close to zero; in others it is as high as one in four abnormal results.
generic viagra online
No Improvement In Detecting Cervical Cancer With Addition Of HPV Test In Cervical Screening Programme In The UK
An article published Online First and in the July edition of The Lancet Oncology reports that the combination of human papillomavirus (HPV) testing with regular liquid-based cytology (LBC) screening does not improve the detection of cervical cancer compared with LBC screening alone.
News of the day
Development of Compact Gamma Camera For Imaging Of Prostate Cancer
The U.S. Department of Energy"s Brookhaven National Laboratory and Hybridyne Imaging Technologies, Inc., of Toronto, Canada, have won a 2009 R&D 100 Award for developing a compact gamma camera for high-resolution imaging of prostate cancer. The camera system, called ProxiScan, is a nuclear medical instrument that can localize cancer tissue in the prostate gland in detail at an early stage, which is important for the successful diagnosis and early treatment of the potentially deadly disease.
Public Health

Fifteen Approved Active Pharmaceutical Ingredients Added To Pharmaceutical Substances Version 3.2

Thieme Publishing Group is pleased to announce the launch of Pharmaceutical Substances Version 3.2. Available via Thieme-connect, Pharmaceutical Substances is a comprehensive reference guide to every significant pharmaceutical compound and includes all FDA approved active pharmaceutical ingredients (APIs). Fifteen drugs have been added to the upgraded version of the information re, bringing the total of APIs to 2,475. Recent additions include Novartis" new anti Malaria drug Riamet, the Japan-only available anti-psychotic drug, Lonasen from Sumitomo Pharma and Evoltra, Bioenvision"s new Leukemia treatment. And the monograph for Dexrazoxane has been updated with new synthetic routes. "We strive to keep Pharmaceutical Substances as current as possible. With this update, important drugs that were approved in the last two years, but not yet covered in the product, have been added," says Dr. Thomas Krimmer, who is in charge of Pharmaceutical Substances at Thieme. "The update is available from mid-May for the users of Thieme"s structure- and full text searchable stand-alone electronic version and from the end of this month for the users of the STN version." Compiled by leaders in the field of pharmaceutical chemistry, in association with InfoChem and FIZ Chemie, the online version of the information re is an easy-to-navigate, web-based portal that utilizes standard browser technology. The user-friendly interface enables users to rapidly locate data and graphically search structures. Thieme


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):